Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSUTINIB vs BOTULINUM TOXIN TYPE A: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSUTINIB vs BOTULINUM TOXIN TYPE A: Safety Overview

Metric BOSUTINIB BOTULINUM TOXIN TYPE A
Total FAERS Reports 7,777 3,742
Deaths Reported 680 1,288
Death Rate 8.7% 34.4%
Hospitalizations 1,675 1,536
Average Patient Age 64.7 yrs 44.1 yrs
% Female Patients 51.8% 78.8%
FDA Approval Date May 23, 2025 N/A
Manufacturer U.S. Pharmaceuticals Evolus, Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription N/A